Coronary Stents

NIRxcell™

Demonstrated exceptionally low TLR rate of 5.1% at 9 months and superior deliverability with the Flexx2 delivery system.

EluNIR™

EluNIRTM demonstrated outstanding results including a 12 month TLF of 5.4%, TLR of 3.0%, and Late Stent Thrombosis of 0.0%.